Drug General Information
Drug ID
D02LML
Former ID
DNC008273
Drug Name
N-methyl-2,2,2-triphenylacetamide
Indication Discovery agent Investigative [529274]
Canonical SMILES
CNC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
1S/C20H19N/c1-21-20(17-11-5-2-6-12-17,18-13-7-3-8-14-18)19-15-9-4-10-16-19/h2-16,21H,1H3
InChIKey
IYYLZMUMLWEPGS-UHFFFAOYSA-N
Target and Pathway
Target(s) Calcium-activated potassium channel Target Info Inhibitor [529274]
References
Ref 529274J Med Chem. 2008 Feb 28;51(4):976-82. Epub 2008 Jan 31.Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
Ref 529274J Med Chem. 2008 Feb 28;51(4):976-82. Epub 2008 Jan 31.Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.